DETECT-Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment
NCT ID: NCT01076608
Last Updated: 2010-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55518 participants
OBSERVATIONAL
2003-09-30
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To answer questions about underlying factors, for this unsatisfactory status, we might profit tremendously from studies that examine the situation, where treatment of patients most frequently take place: in primary care. This approach pays attention to the General Practitioner's (GP) in their gate keeping function in health care. Information from primary care in particular is largely lacking as recently stated by the "Sachverständigenrat für die konzertierte Aktion im Gesundheitswesen" in 2001. The DETECT study has been designed to address these critical issues.
On 16th and 18th September 2003, 3,188 GPs completed a standardised assessment of the diagnostic and therapeutic profile of 55,518 unselected consecutive patients. All patients completed a questionnaire on their demographic data, their complaints, their illness history, their knowledge about selected diseases and their attitude towards those. A sub sample of 7,519 patients additionally attended a standardized laboratory screening program. In this screening the focus was on blood constituents connected with cardiovascular diseases and diabetes, including e. g. cholesterol, lipoproteins, triglycerides and HbA1c. These patients were assessed a second time in the follow up period after one year in 2004 and for a final time after completion of the five-year follow-up period.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. From the cross sectional part (descriptive epidemiological part on 16th/18th September 2003)
* Frequency, characteristics and severity of cardiovascular diseases, selected associated metabolic syndromes and atherosclerotic diseases and syndromes
* Identification and determination of the proportion of patients with high-risk constellations (e.g., post myocardial infarction, associated morbidities, laboratory measures)
* Rates of General Practitioners recognition, diagnostic and therapeutic profiles
* Assessment of quality of care (comparison with guidelines)
* Indicators of undertreatment, overtreatment and inadequate treatment
II. From the longitudinal part
Changes of laboratory parameters and diagnoses after one and five years, in relation to:
* Initial diagnostic and therapeutic status
* Selected intervention criteria
* Composition of risk indicators, and comparison with existing indices (PROCAM, Framingham, Score etc.)
* Measurement of frequency and point of critical outcomes e.g., myocardial infarction, associated morbidity, hospitalisation, critical medical interventions
* Significance of established and "new" cardiovascular risk factors
* Prognostic value of biomarkers for risk stratification
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johann Wolfgang Goethe University Hospital
OTHER
Max-Planck-Institute of Psychiatry
OTHER
University of Magdeburg
OTHER
Medical University of Graz
OTHER
Universitätsklinikum Hamburg-Eppendorf
OTHER
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Institute for Clinical Psychology and Psychotherapy, Technical University of Dresden, Germany
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hans-Ullrich Wittchen, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Director of the Institute of Clinical Psychology and Psychotherapy at the Technical University of Dresden
References
Explore related publications, articles, or registry entries linked to this study.
Wittchen HU, Glaesmer H, Marz W, Stalla G, Lehnert H, Zeiher AM, Silber S, Koch U, Bohler S, Pittrow D, Ruf G; DETECT-Study Group. Cardiovascular risk factors in primary care: methods and baseline prevalence rates--the DETECT program. Curr Med Res Opin. 2005 Apr;21(4):619-30. doi: 10.1185/030079905X38187.
Related Links
Access external resources that provide additional context or updates about the study.
Study homepage
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
149092003
Identifier Type: -
Identifier Source: org_study_id